GenePORTER® 2 转染试剂

GenePORTER® 2 Transfection Reagent is a novel lipid formulation specifically designed to provide high transfection efficiencies in a broad range of mammalian cells. GenePORTER 2 Reagent is especially

  • 货号:

GenePORTER® 2 Transfection Reagent is a novel lipid formulation specifically designed to provide high transfection efficiencies in a broad range of mammalian cells. GenePORTER 2 Reagent is especially effective in difficult-to-transfect cells, such as PC-12, macrophages, and primary cells. Developed using a high-throughput transfection assay that screens a large library of cationic lipids, the GenePORTER 2 Reagent was selected based on high transfection efficiency, low cytotoxicity, and exceptional stability. Additionally, because of its minimized interaction with serum components, the GenePORTER 2 Reagent is ideal for transfection in serum containing media.

 

试剂盒成分:

 

成分 \ 货号 Cat. No. T202007 Cat. No. T202015 Cat. No. T202075 Cat. No. T202096
GenePORTER 2 Transfection Reagent 1 vial of dried lipid film 1 vial of dried lipid film 5 vials of dried lipid film 96 vials of dried lipid film
Hydration Buffer 1 vial x 0.75 ml 1 vial x 1.5 ml 5 vials x 1.5 ml None
DNA Diluent 2 vials x 2 ml 4 vials x 2 ml 20 vials x 2 ml 1 vial x 6 ml
DNA Diluent B 1 vial x 4 ml 1 vials x 8 ml 5 vials x 8 ml 1 vial x 8 ml

 

 

保存条件:
The GenePORTER 2 Transfection Reagent is shipped at room temperature. For maximum stability, store all reagents at 4C upon receipt. If stored properly, the dried GenePORTER 2 reagent is stable for 12 months, and the hydrated GenePORTER 2 reagent is stable for 6 months. The Hydration Buffer and DNA Diluent are stable for 12 months.

 

订购信息:

75 rxn kit, 0.75 ml, T202007

150 rxn kit, 1.5 ml, T202015

750 rxn kit, 5 x 1.5 ml, T202075

QuikEase kit, 96 single-use tubes, T202096

DNA Diluent, 5 x 8 ml, T20DA05

DNA Diluent, 10 x 8 ml, T20DA10

DNA Diluent B, 5 x 8 ml, T20DB05

DNA Diluent B, 10 x 8 ml, T20DB10

 

 

GenePORTER 2 Cell Line Citations: 3T3-L1, A549, AD293, alpha-T3, B103, BCBL-1, BV2, C2C12,Caco-2, CHO, CHO CHO-K1, CHO-K1, CL3, COLO 320DM, COS-1, COS-7, GH4C1, GP202, H19-7, HaCaT, HEK 293, HEK 293 HEK 293T HEK EBNA, HEK-293T, HeLa, HEp-2, Hep3B, HepG2, HT 1080, HUVEC, IB3.1, JEG3, K562, KB, KNRK, L929, LbetaT2, MCF-7, MDBK, MDCK, MEF, MEF-3T3, NC-37, NCI-H23, NIH-3T3, P19, PC-12, PC-3, Phi-NX, PLC ,Primary Retinal Pericytes, Primary Dermal Cells, Primary HPAEC, Primary Pulmonary Artery Endothelium, Primary Osteoblasts, Primary Astrocytes, Primary Keratinocyte, Primary Fetal Kidney, Primary Dermal Fibroblast, Primary Keratinocytes, Primary PASMC, PtK2, Rat-1, RAW 264.7, RAW264.7, RBL-2H3, Saos-2, SH-SY5Y, SiHa, SNB19, SW13, SW1353, TKPTS, Φ NX, Phi NX.

US Patent 6,348,499

 

  • High transfection efficiencies in difficult-to-transfect cells

  • Compatibility with serum-containing media

  • Low cytotoxicity